Question: is bidil still on the market?
Answer: For more than a decade now the drug, BiDil (the combination of two generic drugs, hydralazine and isosorbide dinitrite, or H-ISDN) has been a controversial and spectacularly unsuccessful cardiology drug. BiDil is now owned by Arbor Pharmaceuticals, which is headquartered in Price's Atlanta district.